Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 183, Issue 3, Pages 745-757Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2013.05.032
Keywords
-
Categories
Funding
- Senior Principal Research Fellowship [571123]
- National Health and Medical Research Council (NHMRC) of Australia [632698]
- Muscular Dystrophy Association USA [199272]
- NHMRC [571084]
Ask authors/readers for more resources
Friedreich ataxia (FA) is a neurodegenerative and cardiodegenerative disease resulting from marked frataxin deficiency. The condition is characterized by ataxia with fatal cardiomyopathy, but the pathogenic mechanisms are unclear. We investigated the association between gene expression and progressive histopathological and functional changes using the muscle creatine kinase conditional frataxin knockout (KO) mouse; this mouse develops a severe cardiac phenotype that resembles that of FA patients. We examined KO mice from 3 weeks of age, when they are asymptomatic, to 10 weeks of age, when they die of the disease. Positive iron staining was identified in KO mice from 5 weeks of age, with markedly reduced cardiac function from 6 weeks. We identified an early and marked up-regulation of a gene cohort responsible for stress-induced amino acid biosynthesis and observed markedly increased phosphorylation of eukaryotic translation initiation factor 2 alpha (p-eIF2 alpha), an activator of the integrated stress response, in KO mice at 3 weeks of age, relative to wild-type mice. Importantly, the eIF2 alpha-mediated integrated stress response has been previously implicated in heart failure via downstream processes such as autophagy and apoptosis. Indeed, expression of a panel of autophagy and apoptosis markers was enhanced in KO mice. Thus, the pathogenesis of cardiomyopathy in FA correlates with the early and persistent eIF2 alpha phosphorylation, which precedes activation of autophagy and apoptosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available